Market News / Story
Corteva upgraded at J.P. Morgan following spinoff of Vylor
Seeking Alpha ·
Seeking Alpha reports: J.P. Morgan on Tuesday upgraded Corteva to Overweight from Neutral, arguing that the agricultural-chemicals company left behind after the spinoff of its seed business is undervalued and has a stronger financial profile than its share price suggests. Lead analyst Jeffrey J. Zekauskas set a December 2027 price target of $19, compared with Corteva’s Oct. 5 closing price of $12.39. The target implies upside of about 53%. The sharp reduction from J.P. Morgan’s previous $83…